July 18, 2024

Network-based Identification of Key Proteins and Repositioning of Drugs for Non-Small Cell Lung Cancer network-based-identification-of-key-proteins-and-repositioning-of-drugs-for-non-small- cell-lung-cancer

NSCLC is a highly prevalent cancer and accounts for 85% of cases of lung cancer. Conventional cancer treatments, such as

Network-based Identification of Key Proteins and Repositioning of Drugs for Non-Small Cell Lung Cancer network-based-identification-of-key-proteins-and-repositioning-of-drugs-for-non-small- cell-lung-cancer Read Post »

Scroll to Top